withanolide d has been researched along with withaferin a in 9 studies
| Studies (withanolide d) | Trials (withanolide d) | Recent Studies (post-2010) (withanolide d) | Studies (withaferin a) | Trials (withaferin a) | Recent Studies (post-2010) (withaferin a) |
|---|---|---|---|---|---|
| 25 | 0 | 11 | 590 | 22 | 454 |
| Protein | Taxonomy | withanolide d (IC50) | withaferin a (IC50) |
|---|---|---|---|
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.585 | |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.047 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.047 | |
| Transcription factor p65 | Homo sapiens (human) | 0.047 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Batista, PHJ; Gunatilaka, AAL; Mafezoli, J; Minguzzi, S; Oliveira, MCF; Pessoa, ODL; Whitesell, L; Wijeratne, EMK; Xu, YM | 1 |
| Cuendet, M; Freitas Misakyan, MF; Gunatilaka, AAL; Issa, ME; Monteillier, A; Wijeratne, EMK; Xu, YM | 1 |
| Chowdhury, K; Neogy, RK | 1 |
| Chakraborti, SK; Chatterjee, S | 1 |
| Jha, S; Ray, S | 1 |
| Choudhary, MI; Ganzera, M; Khan, IA | 1 |
| Bargagna-Mohan, P; Mohan, R; Ravindranath, PP | 1 |
| Kumar, G; Patnaik, R | 1 |
| Choi, SM; Dash, R; Hannan, MA; Haque, MN; Moon, IS | 1 |
9 other study(ies) available for withanolide d and withaferin a
| Article | Year |
|---|---|
Withaferin A and Withanolide D Analogues with Dual Heat-Shock-Inducing and Cytotoxic Activities: Semisynthesis and Biological Evaluation.
Topics: Biological Products; Cell Line; Cell Line, Tumor; Cytotoxins; Heat-Shock Response; HEK293 Cells; Humans; Iodine; Organophosphorus Compounds; Sarcoma, Ewing; Structure-Activity Relationship; Withanolides | 2018 |
Structure-Activity Relationships of Withanolides as Antiproliferative Agents for Multiple Myeloma: Comparison of Activity in 2D Models and a 3D Coculture Model.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Coculture Techniques; Humans; Molecular Structure; Multiple Myeloma; Structure-Activity Relationship; Withania; Withanolides | 2021 |
Mode of action of Withaferin A and Withanolide D.
Topics: Animals; Antineoplastic Agents; Cholestenes; Cholestenones; Depression, Chemical; Ethers, Cyclic; Lactones; Male; Mice; Neoplasm Transplantation; Phenylalanine; RNA, Neoplasm; Sarcoma 180; Transplantation, Homologous; Uracil; Withanolides | 1975 |
Antimicrobial activities of some antineoplastic and other withanolides.
Topics: Antineoplastic Agents; Aspergillus niger; Bacillus; Bacteria; Candida albicans; Enterobacteriaceae; Ergosterol; Fungi; Lactones; Saccharomyces cerevisiae; Staphylococcus aureus; Structure-Activity Relationship; Withanolides | 1980 |
Production of withaferin A in shoot cultures of Withania somnifera.
Topics: Adenine; Agar; Antineoplastic Agents, Phytogenic; Benzyl Compounds; Carbon; Culture Media; Culture Techniques; Ergosterol; Kinetin; Plant Extracts; Plant Growth Regulators; Plant Shoots; Purines; Solanaceae; Withanolides | 2001 |
Quantitative HPLC analysis of withanolides in Withania somnifera.
Topics: Chromatography, High Pressure Liquid; Ergosterol; Humans; Phytotherapy; Plant Extracts; Plant Leaves; Plant Roots; Plant Stems; Reproducibility of Results; Withania; Withanolides | 2003 |
Small molecule anti-angiogenic probes of the ubiquitin proteasome pathway: potential application to choroidal neovascularization.
Topics: Angiogenesis Inhibitors; Blotting, Western; Cells, Cultured; Choroid; Choroidal Neovascularization; Endothelium, Vascular; Ergosterol; Growth Substances; Heme Oxygenase-1; Humans; I-kappa B Proteins; Neovascularization, Physiologic; NF-KappaB Inhibitor alpha; Plant Extracts; Plants, Medicinal; Proteasome Endopeptidase Complex; Ubiquitin; Umbilical Veins; Withanolides | 2006 |
Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study.
Topics: Allosteric Site; Blood-Brain Barrier; Humans; Ligands; Molecular Conformation; Molecular Docking Simulation; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotection; Phytochemicals; Receptors, N-Methyl-D-Aspartate; Sitosterols; Withania; Withanolides | 2016 |
Integrated System Pharmacology and
Topics: Alzheimer Disease; Computer Simulation; Glycogen Synthase Kinase 3 beta; Humans; Phosphatidylinositol 3-Kinases; Plant Extracts; Sitosterols; Withania; Withanolides | 2020 |